Literature DB >> 24990143

The contraception needs of the perimenopausal woman.

Sarah M R Hardman1, Ailsa E Gebbie2.   

Abstract

Perimenopausal women have low fertility but must still be advised to use contraception until natural sterility is reached if they are sexually active. Patterns of contraceptive use vary in different countries worldwide. Long-acting reversible contraceptive methods offer reliable contraception that may be an alternative to sterilisation. Hormonal methods confer significant non-contraceptive benefits, and each individual woman should weigh up the benefits and risks of a particular method. No method of contraception is contraindicated by age alone, although combined hormonal contraception and injectable progestogens are not recommended for women over the age of 50 years. The intrauterine system has particular advantages as a low-dose method of effective hormonal contraception, which also offers control of menstrual dysfunction and endometrial protection in women requiring oestrogen replacement. Condoms are recommended for personal protection against sexually transmitted infections in new relationships. Standard hormone replacement therapy is not a method of contraception.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  hormonal contraception; hormone replacement therapy; intra-uterine contraception; non-contraceptive benefits; perimenopause

Mesh:

Substances:

Year:  2014        PMID: 24990143     DOI: 10.1016/j.bpobgyn.2014.05.006

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  1 in total

Review 1.  Contraception pathway: application for midlife women.

Authors:  Chi-Son Kim; Deanna Tikhonov; Lena Merjanian; Adrian C Balica
Journal:  Womens Midlife Health       Date:  2017-10-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.